NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 28 filers reported holding NIVALIS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,195,013 | $9,249,000 | 1.58% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,732,412 | $28,889,000 | 1.17% |
| TIGER MANAGEMENT L.L.C. | 650,915 | $5,038,000 | 0.65% |
| RA Capital Management | 612,863 | $4,744,000 | 0.47% |
| WALL STREET ASSOCIATES | 170,400 | $1,319,000 | 0.37% |
| Rock Springs Capital Management LP | 489,000 | $3,785,000 | 0.29% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,548 | $1,792,000 | 0.26% |
| SABBY MANAGEMENT, LLC | 503,595 | $3,898,000 | 0.21% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 399,663 | $3,093,000 | 0.15% |
| DAFNA Capital Management LLC | 15,000 | $116,000 | 0.10% |